课题基金 / 基金详情

项目摘要

项目成果

SHERRY CHOW的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The National Cancer Institute (NCI), Division of Cancer Prevention (DCP) Phase 0/I/II Cancer Prevention Clinical Trials Program supports early clinical trials to rapidly evaluate the clinical activity and biologic effects of cancer preventive agents of interest to DCP. The agents to be studied shall include agents developed by the pharmaceutical industry and provided to DCP for collaborative development, commercially available agents, and agents developed by DCP. The objectives of this Task Order are to provide the core infrastructure to support the conduct of the clinical trials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
  • 批准号:
    10690412
  • 项目类别:
  • 资助金额:
    $24.29万
  • 财政年份:
    2019
  • 负责人:
    SHERRY CHOW
  • 依托单位:
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
  • 批准号:
    10451452
  • 项目类别:
  • 资助金额:
    $24.29万
  • 财政年份:
    2019
  • 负责人:
    SHERRY CHOW
  • 依托单位:
CORE INFRASTRUCTURE SUPPORT FOR THE CANCER PREVENTION AGENT DEVELOPMENT PROGRAM
  • 批准号:
    10045659
  • 项目类别:
  • 资助金额:
    $63.89万
  • 财政年份:
    2019
  • 负责人:
    SHERRY CHOW
  • 依托单位:
IGF::OT::IGF M4OC-PREVENT: METFORMIN FOR ORAL CANCER PREVENTION
  • 批准号:
    9162592
  • 项目类别:
  • 资助金额:
    $72.22万
  • 财政年份:
    2015
  • 负责人:
    SHERRY CHOW
  • 依托单位:
    --
国内基金
海外基金
Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data